October 2014 InSight Issue


Cooper Companies, Inc. completes Sauflon acquisition

The Cooper Companies, Inc. (NYSE:COO) has completed its previously announced acquisition of Sauflon Pharmaceuticals Ltd., a European manufacturer. 
Read More.

Biofinity outperforms leading competitors

Patients have named Biofinity as their lens of choice against the leading competitors, Air Optix Aqua sphere and Air Optix for Astigmatism, in a recent clinical study. 
Read More

Addressing Contact Lens Wear and Diabetes

Gain insights to a recent roundtable event ‘Managing Contact Lens Wear in Patients with Diabetes’ as Dr. Gary Orsborn shares the key messages from the event. 
Read More.

Assessing the Value of the Contact Lens Patient

Find out the long-term value of your contact lens patients in this focus series, featured in Review of Optometric Business and Vision Monday. 
Read More.

New Mobile App Helps Your Patients with Compliance

Helping your patients with contact lens compliance is now easier than ever, thanks to CooperVision’s new mobile app which provides valuable information. 
Read More.


← Back to InSight Newsletter Archive